Loading, please wait...
Basics of Chemotherapy Compounding with a Review of USP <800> Training Program
Target audience: Pharmacists and Pharmacy Technicians
This course is designed to train pharmacists and pharmacy technicians in basics of chemotherapy compounding based on USP <800> standards. This is an introductory chemotherapy compounding course where the participants will receive continuing education credits as well as a certificate of completion. This live one-day workshop will review the USP Chapter 800 standard requirements and provide the practical application of the basics of chemotherapy compounding by emphasizing the hands-on practice at the individual level. The participant will complete the core competences required by current USP Chapter <800> standards in a state-of -the art facility.
Participant Requirements: Completion of the basic aseptic technique course or prior sterile compounding experience is highly recommended before taking this course. To receive continuing education credit for this program, participant must be a registered pharmacist or registered pharmacy technician, attend all sessions and successfully demonstrate competencies. Participant must physically be able to stand for a minimum of 2 hour periods and must have manual dexterity to allow manipulation of needles, syringes and other products utilized to prepare hazardous drug products. Participant must also have full range of motion to complete physical tasks required in the compounding processes.
Statement of Need: Hazardous drugs (focus on chemotherapy) are an important part of patient and pharmaceutical care in the US healthcare system. The literature indicates an increasing concern for healthcare professional safety with regards to inadvertent exposure to hazardous drugs during the preparation and administration of these treatments. Proper technique and training are paramount to preparing hazard drug prescriptions so that not only patient but also healthcare professional safety is achieved. Major changes related to hazardous drugs have occurred in the regulatory environment. In addition, new safety devices and equipment are emerging in the marketplace. These changes will create a need for pharmacy practitioners to understand the regulatory changes as well the proper utilization of safety equipment and devices in pharmacy practice. This course will provide a much needed foundation training program in handling hazardous drug compounds with numerous opportunities for hands-on application and competency demonstration.
Program Description:
Basics of Chemotherapy Compounding with a Review of USP <800> Training Program is an intensive education experience designed to equip pharmacists, and pharmacy technicians with immersive, hands on training in the safe handling and preparation of hazardous drug products (focus on chemotherapy). Learners will be provided training in the USP regulatory requirements and best practices to promote healthcare personnel and patient safety when utilizing hazardous drug compounds.
The live sessions incorporate didactic training and hands on skills training focused on the current requirements and best practices in preparation for situations most likely to be encountered when pharmacy personnel are preparing hazardous drugs. Program participants will receive training on the regulatory standards and best practices related to donning personal protective equipment, proper utilization and maintenance of equipment utilized with hazardous drug compounding, proper technique and utilization of closed system transfer devices (CSTDs), and proper cleaning and spill control related to hazardous drugs. Learners must successfully demonstrate competency via various hands-on simulations in the state of the art compounding facility. The training course content will be delivered through the use of didactic training, live demonstrations, hands-on simulation training, and practical skill assessments.
CE credit amount: 8 hours Live CE
Instructors:
- Nancy Roberts, PharmD, MS
- Sterile Compounding Training, Program Director, Kennedy Pharmacy Innovation Center (KPIC), University of South Carolina College of Pharmacy
- Carl Dunn, RPh
- Pharmacist, Intramed Plus, West Columbia, SC
- Shay Garrison, RPh, MPH
- Pharmacy Manager, Palmetto Richland Hospital
Program Cancellation and Refund Policy:
Cancellation Policy: Cancellations received in writing at least 30 days prior to program date via letter or email to ce@sccp.sc.edu will receive a full refund minus a $200 cancellation fee.
SCCP reserves the right to cancel the entire program. In the event of a conference cancellation, each participant will be notified via phone and/or email at least 14 days prior to the program and a full tuition refund will be made.
In the event of inclement weather, the decision to cancel a course will be made no later than 9:00 am Eastern time the day before the program.
Registration transfers
Individuals attending the course in place of the registered individual will be honored as long as the request is made in advance of the registration deadline, which is 14 days prior to the start of the live component. Transfer participants must still complete the required pre-requisite self-study by the required cut-off date.
Individuals attending the course in place of the registered individual will be honored as long as the request is made in advance of the registration deadline, which is 14 days prior to the start of the live component. Transfer participants must still complete the required pre-requisite self-study by the required cut-off date.
Refunds
Refund requests are subject to a $200.00 cancellation fee and must be received 30 days prior to the start of the live component. All registration cancellations must be submitted in writing or by e-mail to the Continuing Education Department at the following address.
Refund requests are subject to a $200.00 cancellation fee and must be received 30 days prior to the start of the live component. All registration cancellations must be submitted in writing or by e-mail to the Continuing Education Department at the following address.
South Carolina College of Pharmacy – USC Campus
Continuing Education
Continuing Education
715 Sumter Street, Room 318
Columbia, SC 29208
Email: ce@SCCP.sc.edu
Email: ce@SCCP.sc.edu
Registrants may receive 100% of the program registration fees, less the $200.00 cancellation fee up to 30 days prior to start date of the live component. No refunds are offered for cancellations fewer than 30 days prior to the start date of the live component or for no shows.
RSVP Information and cut-off date: Registration will be accepted until 14 days prior to the start of the live practice based component or until capacity has been reached.
There is no commercial support for this program.
Location of event: The training program will be offered at the Aseptic Compounding Experience (ACE) Lab, located at 715 Sumter Street, South Carolina College of Pharmacy -University of South Carolina campus in Columbia, SC.
Continuing Pharmacy Education (CPE) Information and Activity Completion Requirements:
For successful completion for the live activity, participants will be required to attend the accredited program in its entirety, successfully demonstrate practice based competencies using planned simulations, and complete speaker and program evaluations. This activity has been approved for 8 contact hours (0.8 CEUs) of live continuing education credit. ACPE# 0062-0000-17-145-L07-P/T.
Activity type: This is an application based learning activity
Initial Release Date: 10/22/2017
Expiration Date: 10/22/2020
Credit claimed will be automatically uploaded to CPE Monitor. If learner wants a hard copy statement of credit, it can be printed electronically and/or transcript from their CPE Monitor profile. For participants that complete the entire program, Certificates of Completion will be provided.
Contact Information:
If you have questions about this CPE activity, please contact the SCCP CE office at 803-777-9979 or ce@sccp.sc.edu.
Disclosure Statements:
Faculty Disclosures: The presenters have disclosed no relevant financial relationships.
The planners, reviewers, staff and CME committee who control content have no relevant financial relationships to disclose.
Schedule:
|
Time
|
Topic
|
Format/Location
|
|
8:00– 9:30am
|
Overview of Hazardous Drugs - Regulatory Guidance and Best Practices (Part 1)
|
Lecture -CLS 010
|
|
9:30– 9:45 am
|
Break
|
|
|
9:45 - 11:15am
|
Overview of Hazardous Drugs - Regulatory Guidance and Best Practices (Part 2)
|
Lecture -CLS 010
|
|
11:15 - 12:15 pm
|
Personal Protective Equipment for Hazardous Drugs (Exercise 1)
|
Demo/Hands on Simulation, Competency -ACE LAB
|
|
12:15-1:00pm
|
Lunch
|
|
|
1:00pm -2:00 pm
|
Compounding Hazardous Drugs (Part 1)
(Exercise 2)
|
Demonstration/Hands on Simulation – CLS 010
|
|
2:00-4:00 PM
|
Compounding Hazardous Drugs (Part 2)
(Exercise 3)
|
Hands-on Simulation, Competency-ACE lab/CLS 010
|
|
4:00-4:15 pm
|
Break
|
|
|
4:15pm – 5:15 pm
|
Environmental Quality Control & Cleaning
(Exercise 4)
|
Lecture/Demonstration -
ACE LAB
|
Date: Oct 22, 2017 08:00 AM - 05:15 PM
Fee
$450.00
CE Hours
8.00
CE Units
0.800
Registration closes on Oct 08, 2017 11:55 PM
Activity Type
- Application
Target Audience(s)
- Pharmacists
- Pharmacy Technicians
Accreditation(s)
|
The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Registration Closed
Registration Closed
At the completion of this activity, the participant will be able to:
1. Summarize USP chapter requirements for hazardous drug compounding and highlight key requirements and
agencies associated with HD guidelines
2. Define hazardous drugs and exposure risks
3. Discuss the role of facility design, secondary engineering controls and primary engineering controls in
compounding hazardous drugs
4. Identify the personal protective equipment used specifically for compounding hazardous drugs
5. Describe and demonstrate proper procedures for deactivation/decontamination, cleaning, and disinfection of
SECs and PECs used for compounding HDs
6. Explain environmental controls for minimizing exposure to HDs: storage, general handling, labeling and
transport
7. Define and properly utilize closed system transfer devices (CSTDs).
8. Discuss and demonstrate spill management and disposal of HD waste
9. Outline requirements and competencies for training of compounding personnel
10. Define medical surveillance
11. Demonstrate proper donning and removal of PPE
12. Demonstrate proper aseptic technique using negative pressure technique
13. Demonstrate proper aseptic technique using CSTD and priming IV
1. Summarize USP chapter requirements for hazardous drug compounding and highlight key requirements and
agencies associated with HD guidelines
2. Define hazardous drugs and exposure risks
3. Discuss the role of facility design, secondary engineering controls and primary engineering controls in
compounding hazardous drugs
4. Identify the personal protective equipment used specifically for compounding hazardous drugs
5. Describe and demonstrate proper procedures for deactivation/decontamination, cleaning, and disinfection of
SECs and PECs used for compounding HDs
6. Explain environmental controls for minimizing exposure to HDs: storage, general handling, labeling and
transport
7. Define and properly utilize closed system transfer devices (CSTDs).
8. Discuss and demonstrate spill management and disposal of HD waste
9. Outline requirements and competencies for training of compounding personnel
10. Define medical surveillance
11. Demonstrate proper donning and removal of PPE
12. Demonstrate proper aseptic technique using negative pressure technique
13. Demonstrate proper aseptic technique using CSTD and priming IV
Speaker(s)/Author(s)
|
Aaron Masavage, PharmD
|
|
|
Carl Dunn, RPh
|
|
|
Nancy Roberts, PharmD, MS
|
|
|
Richard Capps, PharmD
|
|
|
Shay Garrison, RPh, MPH
|
Activity Number
0062-0000-17-145-L07-P/T
Date:
10/22/17
Time:
08:00 AM - 05:15 PM
CE Hours
8.00
Registration Closed